| Description | BMS-593214 is a selective active site-directed factor VIIa inhibitor and a non-competitive inhibitor of the VIIa-activated substrate, FX, with antithrombotic and antihemorrhagic activity.BMS-593214 can be used to study electrically-induced carotid artery thrombosis (AT) and wire-induced vena cava thrombosis (VT).BMS-593214 has been shown to be an antithrombotic inhibitor of the VIIa activating substrate, FX, with antithrombotic and antihemorrhagic activity. |
| Synonyms | BMS593214, BMS 593214 |
| molecular weight | 505.56 |
| Molecular formula | C31H27N3O4 |
| CAS | 1004551-40-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 80 mg/mL (158.24 mM), Sonication is recommended. |
| References | 1. Wong PC, et al. BMS-593214, an active site-directed factor VIIa inhibitor: enzyme kinetics, antithrombotic and antihaemostatic studies. Thromb Haemost. 2010 Aug;104(2):261-9. |